| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Topical Review |
1 Department of Metabolic Medicine, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8554, Japan
2 Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
AMPK is a serine/threonine protein kinase, which serves as an energy sensor in all eukaryotic cell types. Published studies indicate that AMPK activation strongly suppresses cell proliferation in non-malignant cells as well as in tumour cells. These actions of AMPK appear to be mediated through multiple mechanisms including regulation of the cell cycle and inhibition of protein synthesis, de novo fatty acid synthesis, specifically the generation of mevalonate as well as other products downstream of mevalonate in the cholesterol synthesis pathway. Cell cycle regulation by AMPK is mediated by up-regulation of the p53–p21 axis as well as regulation of TSC2–mTOR (mammalian target of rapamycin) pathway. The AMPK signalling network contains a number of tumour suppressor genes including LKB1, p53, TSC1 and TSC2, and overcomes growth factor signalling from a variety of stimuli (via growth factors and by abnormal regulation of cellular proto-oncogenes including PI3K, Akt and ERK). These observations suggest that AMPK activation is a logical therapeutic target for diseases rooted in cellular proliferation, including atherosclerosis and cancer. In this review, we discuss about exciting recent advances indicating that AMPK functions as a suppressor of cell proliferation by controlling a variety of cellular events in normal cells as well as in tumour cells.
(Received 23 February 2006;
accepted after revision 11 April 2006;
first published online 13 April 2006)
Corresponding author H. Motoshima: Department of Metabolic Medicine, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 8554, Japan. Email: hmoto{at}gpo.kumamoto-u.ac.jp
This article has been cited by other articles:
|
|
 |
|
  S. Yu, G. Shen, T. O. Khor, J.-H. Kim, and A.-N. T. Kong Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism Mol. Cancer Ther., September 1, 2008; 7(9): 2609 - 2620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhu, W. Jiang, J. L. Sells, E. S. Neil, J. N. McGinley, and H. J. Thompson Effect of Nonmotorized Wheel Running on Mammary Carcinogenesis: Circulating Biomarkers, Cellular Processes, and Molecular Mechanisms in Rats Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1920 - 1929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Blandino-Rosano, G Perez-Arana, J M Mellado-Gil, C Segundo, and M Aguilar-Diosdado Anti-proliferative effect of pro-inflammatory cytokines in cultured {beta} cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1 J. Mol. Endocrinol., July 1, 2008; 41(1): 35 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jiang, Z. Zhu, and H. J. Thompson Dietary Energy Restriction Modulates the Activity of AMP-Activated Protein Kinase, Akt, and Mammalian Target of Rapamycin in Mammary Carcinomas, Mammary Gland, and Liver Cancer Res., July 1, 2008; 68(13): 5492 - 5499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lee, J. S. Cho, N. Lambacher, J. Lee, S.-J. Lee, T. H. Lee, A. Gartner, and H.-S. Koo The Caenorhabditis elegans AMP-activated Protein Kinase AAK-2 Is Phosphorylated by LKB1 and Is Required for Resistance to Oxidative Stress and for Normal Motility and Foraging Behavior J. Biol. Chem., May 30, 2008; 283(22): 14988 - 14993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Kim, J.-T. Hwang, H. Yun, S.-G. Chi, S.-J. Lee, I. Kang, K.-S. Yoon, W.-J. Choe, S.-S. Kim, and J. Ha Inhibition of AMP-activated Protein Kinase Sensitizes Cancer Cells to Cisplatin-induced Apoptosis via Hyper-induction of p53 J. Biol. Chem., February 15, 2008; 283(7): 3731 - 3742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, Y. Dong, J. Xu, Z. Xie, Y. Wu, P. Song, M. Guzman, J. Wu, and M.-H. Zou Thromboxane Receptor Activates the AMP-Activated Protein Kinase in Vascular Smooth Muscle Cells via Hydrogen Peroxide Circ. Res., February 15, 2008; 102(3): 328 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Young AMP-Activated Protein Kinase Conducts the Ischemic Stress Response Orchestra Circulation, February 12, 2008; 117(6): 832 - 840. [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Beale 5'-AMP-Activated Protein Kinase Signaling in Caenorhabditis elegans Experimental Biology and Medicine, January 1, 2008; 233(1): 12 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Burhans and M. Weinberger DNA replication stress, genome instability and aging Nucleic Acids Res., December 3, 2007; 35(22): 7545 - 7556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shimanuki, S.-Y. Chung, Y. Chikashige, Y. Kawasaki, L. Uehara, C. Tsutsumi, M. Hatanaka, Y. Hiraoka, K. Nagao, and M. Yanagida Two-step, extensive alterations in the transcriptome from G0 arrest to cell division in Schizosaccharomyces pombe Genes Cells, May 1, 2007; 12(5): 677 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-Y. Su, Y. Chao, T.-Y. Chen, D.-Y. Huang, and W.-W. Lin 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling Mol. Cancer Ther., May 1, 2007; 6(5): 1562 - 1571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dasgupta and J. Milbrandt Resveratrol stimulates AMP kinase activity in neurons PNAS, April 24, 2007; 104(17): 7217 - 7222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, W. F. Han, L. E. Landree, J. N. Thupari, M. L. Pinn, T. Bililign, E. K. Kim, A. Vadlamudi, S. M. Medghalchi, R. El Meskini, et al. Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells Cancer Res., April 1, 2007; 67(7): 2964 - 2971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Khan, F. Afaq, M.-H. Kweon, K. Kim, and H. Mukhtar Oral Consumption of Pomegranate Fruit Extract Inhibits Growth and Progression of Primary Lung Tumors in Mice Cancer Res., April 1, 2007; 67(7): 3475 - 3482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arad, C. E. Seidman, and J.G. Seidman AMP-Activated Protein Kinase in the Heart: Role During Health and Disease Circ. Res., March 2, 2007; 100(4): 474 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fisslthaler, I. Fleming, B. Keseru, K. Walsh, and R. Busse Fluid Shear Stress and NO Decrease the Activity of the Hydroxy-Methylglutaryl Coenzyme A Reductase in Endothelial Cells via the AMP-Activated Protein Kinase and FoxO1 Circ. Res., February 2, 2007; 100(2): e12 - e21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kumar and C. Peers AMP-activated protein kinase: function and dysfunction in health and disease J. Physiol., July 1, 2006; 574(1): 3 - 6. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
